Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2011
- PMID: 21866086
Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2011
Abstract
This document provides updated guidance for the use of influenza vaccines in the United States for the 2011-12 influenza season. In 2010, the Advisory Committee on Immunization Practices (ACIP) first recommended annual influenza vaccination for all persons aged ≥6 months in the United States. Vaccination of all persons aged ≥6 months continues to be recommended. Information is presented in this report regarding vaccine strains for the 2011-12 influenza season, the vaccination schedule for children aged 6 months through 8 years, and considerations regarding vaccination of persons with egg allergy. Availability of a new Food and Drug Administration (FDA)-approved intradermally administered influenza vaccine formulation for adults aged 18 through 64 years is reported. For issues related to influenza vaccination that are not addressed in this update, refer to the 2010 ACIP statement on prevention and control of influenza with vaccines and associated updates.
Similar articles
-
Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP)--United States, 2012-13 influenza season.MMWR Morb Mortal Wkly Rep. 2012 Aug 17;61(32):613-8. MMWR Morb Mortal Wkly Rep. 2012. PMID: 22895385
-
Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010.MMWR Recomm Rep. 2010 Aug 6;59(RR-8):1-62. MMWR Recomm Rep. 2010. PMID: 20689501
-
Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008.MMWR Recomm Rep. 2008 Aug 8;57(RR-7):1-60. MMWR Recomm Rep. 2008. PMID: 18685555
-
Influenza vaccine 2008-2009.Med Lett Drugs Ther. 2008 Oct 6;50(1296):77-9. Med Lett Drugs Ther. 2008. PMID: 18833032 Review.
-
Impact of influenza on young children and the shaping of United States influenza vaccine policy.Pediatr Infect Dis J. 2003 Oct;22(10 Suppl):S231-5. doi: 10.1097/01.inf.0000092194.33331.66. Pediatr Infect Dis J. 2003. PMID: 14551482 Review.
Cited by
-
Antibody response to pneumococcal and influenza vaccination in patients with rheumatoid arthritis receiving abatacept.BMC Musculoskelet Disord. 2016 May 26;17:231. doi: 10.1186/s12891-016-1082-z. BMC Musculoskelet Disord. 2016. PMID: 27229685 Free PMC article. Clinical Trial.
-
Trivalent influenza vaccine-induced antibody response to circulating influenza a (H3N2) viruses in 2010/11 and 2011/12 seasons.Hum Vaccin Immunother. 2015;11(2):386-90. doi: 10.1080/21645515.2015.1009338. Hum Vaccin Immunother. 2015. PMID: 25692378 Free PMC article.
-
Viruses without borders.Can J Infect Dis. 2000 May;11(3):125-6. doi: 10.1155/2000/703523. Can J Infect Dis. 2000. PMID: 18159276 Free PMC article. No abstract available.
-
Influenza vaccines: Evaluation of the safety profile.Hum Vaccin Immunother. 2018 Mar 4;14(3):657-670. doi: 10.1080/21645515.2017.1423153. Epub 2018 Jan 30. Hum Vaccin Immunother. 2018. PMID: 29297746 Free PMC article. Review.
-
Influenza vaccination in children at high risk of respiratory disease.Ther Adv Vaccines. 2013 May;1(1):21-31. doi: 10.1177/2051013613480770. Ther Adv Vaccines. 2013. PMID: 24757513 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical